Search clinical trials for: H1N1 VACCINE

Total 10045 results

International Maternal Pediatric Adolescent AIDS...
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Laboratory Study of Licensed H1N1 Influenza Vaccines in HIV-1 Perinatally Infected Children and Youth

Influenza | HIV-1 Infection | Flu | H1N1

United States, Puerto Rico
National Heart, Lung, and Blood Institute (NHLBI)

Completed

Novel Influenza A (H1N1) Surveillance Registry

Influenza | H1N1 | Novel Influenza A

United States
Hoffmann-La Roche

Completed

A Study of Trastuzumab Emtansine in Indian Patients With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Unresectable Locally Advanced or Metastatic Breast Cancer Who Have Received Prior Treatment With Trastuzumab and a Taxane

HER2 Positive Breast Cancer, Metastatic Breast Cancer, Locally Advanced Breast Cancer

India
New York State Psychiatric Institute
National Institute on Drug Abuse (NIDA)

Completed

Mirtazapine for Treating Cocaine Dependent Individuals Who Also Suffer From Depression

Depression | Cocaine Dependence

United States
National Institute of Mental Health (NIMH)

Completed

Sequenced Treatment Alternatives to Relieve Depression (STAR*D)

Depression

United States
Masonic Cancer Center, University of Minnesota

Terminated

Influenza Vaccine Post Allogeneic Transplant

Hematologic Malignancy | Hematopoietic Stem Cell Transplant

United States
Fondazione Poliambulanza Istituto Ospedaliero
Associazione Italiana per la Ricerca sul Cancro

Recruiting

The ADAPTA Study: ADjuvant chemotherAPy After Curative Intent resecTion of Ampullary Cancer. (ADAPTA)

Ampullary Adenocarcinoma

Italy
Kaohsiung Medical University Chung-Ho Memorial...

Recruiting

Naldebain and Video-assisted Thoracoscopic Surgery

Analgesia | Satisfaction, Patient | Itching | Injection Site Reaction | Nausea and Vomiting, Postoperative

Taiwan
Mohamed Saad

Unknown

Role OF OCT-A TO Detect Possible Retinal Vascular Complications of Sofosbuvir in Patients With Hepatitis C

HCV Infection

Egypt
Onconova Therapeutics, Inc.

Completed

Safety Study of ON 01910.Na in Combination With Irinotecan or Oxaliplatin

Advanced Solid Tumors

United States
Prague Psychiatric Center
Eli Lilly and Company

Completed

Study With Information Technology (IT) - Aided Preventive Program in Schizophrenia

Schizophrenia

Czech Republic
Korea University
Taiwan Otsuka Pharm. Co., Ltd; Korea OIAA

Unknown

Aripiprazole Augmentation Versus Switching to Different Class of Antidepressants in Major Depressive Disorder

Major Depressive Disorder

Korea, Republic of, Taiwan
Zagazig University

Recruiting

Clonidine Versus Granisetron for Shivering Prevension

Post Spinal Anesthesia Shivering

Egypt
Brigham and Women's Hospital

Recruiting

Long-term Effects of Blueberry Supplementation on Brain Health in Older Adults

Brain Injuries | Cognitive Decline | Nutrition, Healthy

United States
Arkansas Children's Hospital Research Institute

Active, not recruiting

The Blueberry Study

Healthy

United States
University of Pittsburgh
National Institute on Alcohol Abuse and Alcoholism (NIAAA)

Completed

Double-blind Pilot Trial of Mirtazapine for the Treatment of Co-occurring AD/MDD. (PT-MAD)

Major Depressive Disorder | Alcohol Use Disorder

United States
City of Hope Medical Center
National Cancer Institute (NCI)

Completed

Radiolabeled Monoclonal Antibody Therapy, Combination Chemotherapy, and Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

Stage IV Colon Cancer | Stage IV Rectal Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer

United States
Gilead Sciences

Completed

Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection

Hepatitis C Virus

Egypt
University of Virginia
American Association of Chairs of Departments of Psychiatry

Withdrawn

Dose Response of Mirtazapine to Methamphetamine Induced Interest, Mood Elevation and Reward

Amphetamine Dependence

United States
Universitaire Ziekenhuizen KU Leuven

Unknown

Mirtazapine Versus Placebo in Functional Dyspepsia

Functional Dyspepsia

Belgium
David Scheifele
Canadian Institutes of Health Research (CIHR); PHAC/CIHR Influenza Research...

Completed

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Aboriginal Children and Adults

H1N1/2009 Influenza

Canada
Instituto Nacional de Salud Publica, Mexico
Laboratorios de Biologicos y Reactivos de México, S.A. de C.V.

Withdrawn

Clinical Trial to Evaluate the Immunogenicity and Safety of the Vaccine Against Influenza A/H1N1

Influenza

Mexico
University of Rochester
National Institutes of Health (NIH)

Withdrawn

Effect of Age and Prior Immunity on Response to H1N1 Vaccines in Children (H1N1Children)

2009 H1N1 Influenza

United States
Adimmune Corporation

Completed

Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Adults and Elders

Influenza

Taiwan
Adimmune Corporation

Completed

Immunogenicity and Safety of Influenza Virus Vaccine, AdimFlu-S (A/H1N1), in Pediatric Population

Influenza

Taiwan
David Scheifele
Canadian Institutes of Health Research (CIHR)

Completed

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults Receiving Seasonal Influenza Vaccine

Influenza | H1N1 2009 Influenza

Canada
AVIR Green Hills Biotechnology AG

Completed

Randomized, Double-blind, Placebo-controlled, Phase I Dose-escalation Study of Single Dose GHB01L1 in Healthy Volunteers (GHBCS-01)

Seasonal Human Influenza

Austria
National Institute of Allergy and Infectious Diseases...

Completed

H1N1v Virus Challenge Study in Healthy Subjects

Influenza

United States
GlaxoSmithKline

Completed

Safety and Efficacy of H1N1 Vaccines in Children Aged 6 Months to Less Than 10 Years of Age

Influenza

Thailand, Australia, Mexico, Costa Rica, Philippines, Colombia, Singapore, Brazil
GlaxoSmithKline

Completed

Study of GSK Biologicals' Influenza Vaccine Arepanrix™ in Japanese Adults 65 Years of Age or Older

Influenza

Japan
Shanghai Institute Of Biological Products

Completed

The Long-term Immunogenicity of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine

Influenza

China
Assistance Publique - Hôpitaux de Paris

Completed

Vaccination Against Influenza in Autoimmune Diseases (MAIVAX)

Autoimmune Diseases

France
Mahidol University

Completed

Phase I/II Safety and Immunogenicity of Pandemic Live Attenuated Influenza Vaccine (PLAIV) Candidate Strain A/17/CA/2009/38 (H1N1) in Healthy Thais

Healthy

Thailand
Jiangsu Province Centers for Disease Control and...
Hualan Biological Bacterin Co. Ltd.

Completed

Novel Influenza A/H1N1 Split- Virion Vaccine in Healthy Population Aged 3 Years and Older

Virus Diseases | Respiratory Tract Infections | Respiratory Tract Diseases | Influenza | Orthomyxoviridae Infections

China
Fraunhofer, Center for Molecular Biotechnology
Walter Reed Army Institute of Research (WRAIR); Defense Advanced Research Projects...

Completed

Study of the Safety and Immunogenicity of H1N1 Vaccine

H1N1 Flu

United States
PepTcell Limited
National Institute of Allergy and Infectious Diseases (NIAID)

Completed

Efficacy of FLU-v in an H1N1 Influenza Human Challenge Model

Influenza

United Kingdom
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of Fluarix™ Vaccine in Children Who Have Previously Been Vaccinated With Pandemrix™

Influenza

Sweden, Netherlands
GlaxoSmithKline

Completed

Safety and Immune Response of Candidate H1N1 Influenza Vaccine GSK2340274A Following Seasonal Influenza Vaccination in Adults

Influenza

United States
Vaxart

Completed

Safety Study of an Oral Vaccine to Prevent Seasonal Influenza

Influenza

United States
University of Rochester
National Institutes of Health (NIH)

Completed

Effects of Age on Response to the 2009 H1N1 Virus Vaccine

2009 H1N1 Influenza Virus

United States
University of Rochester

Completed

Infectivity, Replication & Immunogenicity of Live nH1N1 Vaccine

Influenza

United States
University of British Columbia
GlaxoSmithKline; Canadian Institutes of Health Research (CIHR)

Completed

Rapid Evaluation of Pandemic H1N1 Influenza Vaccine in Adults With HIV

HIV Infections | H1N1 Influenza

Canada
University of Miami
National Institute of Allergy and Infectious Diseases (NIAID); Vaccine and...

Completed

Immunogenicity of Inactivated Swine H1N1 Vaccine In HIV Infected Children - The Miami Cohort Study

HIV

United States
Immune Targeting Systems Ltd

Completed

Safety and Reactogenicity of a H1N1 Influenza Challenge Virus in Healthy Volunteers

Influenza A

Belgium
PHAC/CIHR Influenza Research Network
GlaxoSmithKline; CHU de Quebec-Universite Laval; The Ottawa Hospital; Hamilton... and other collaborators

Completed

Surveillance for Adverse Events Following Pandemic H1N1 Immunization

Novel Influenza A/H1N1
PHAC/CIHR Influenza Research Network
University of Manitoba; University of British Columbia; CHU de Quebec-Universite... and other collaborators

Unknown

Clinical Investigation on Allergic-like Reactions and Oculo-respiratory Syndrome After the H1N1 Pandemic Vaccine

Allergy | Anaphylaxis | Oculorespiratory Syndrome | Allergic-like Reactions

Canada
International Centre for Infectious Diseases, Canada
GlaxoSmithKline

Unknown

Effectiveness of H1N1 Influenza Vaccines in Manitoba, Canada

Pneumonia | Influenza

Canada
Shanghai Institute Of Biological Products

Completed

Immunogenicity and Safety of an Inactivated Split-virion 2009 Pandemic Influenza A H1N1 Vaccine in Infants

Influenza

China
Henry M. Jackson Foundation for the Advancement...
National Institute of Allergy and Infectious Diseases (NIAID); Infectious Diseases...

Completed

Immunogenicity of Novel H1N1 Vaccination Among HIV-Infected Compared to HIV-Uninfected Persons

HIV Infections | Influenza

United States
GlaxoSmithKline

Completed

Immunogenicity and Safety Study of FluarixTM Vaccine in Children Who Have Previously Been Vaccinated With PandemrixTM

Influenza

Finland

Search clinical trials for: H1N1 VACCINE

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in El Salvador

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations